OFI Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$30K Buy
1,069
+169
+19% +$6.11K ﹤0.01% 1625
2015
Q2
$37K Sell
900
-168
-16% -$6.16K ﹤0.01% 1607
2015
Q1
$32K Sell
1,068
-401
-27% -$10.4K ﹤0.01% 1631
2014
Q4
$29K Sell
1,469
-85
-5% -$1.9K ﹤0.01% 1639
2014
Q3
$31K Sell
1,554
-32
-2% -$673 ﹤0.01% 1629
2014
Q2
$36K Buy
1,586
+1,524
+2,458% +$27.1K ﹤0.01% 1608
2014
Q1
$1K Buy
+62
New +$889 ﹤0.01% 1716

Other funds holding RGEN

OFI Advisors's RGEN Position: Q3 2015 in Review

OFI Advisors increased its Repligen (RGEN) stake by 19% in Q3 2015, buying an estimated $6.11K and bringing the position to 1,069 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

OFI Advisors first reported a position in RGEN in Q1 2014 and has held it in 7 quarters since. The position peaked at $37K in Q2 2015. 184 funds tracked by Wall St. Rank hold RGEN as of Q3 2015.

  • OFI Advisors held 1,069 shares of Repligen worth $30K as of Q3 2015.
  • OFI Advisors bought 169 Repligen shares in Q3 2015, an estimated $6.11K.
  • Repligen made up ﹤0.01% of OFI Advisors's portfolio in Q3 2015, its #1625 holding.
  • OFI Advisors first reported a position in Repligen in Q1 2014 and has held it in 7 quarters since.
  • OFI Advisors's Repligen position peaked at $37K in Q2 2015.
  • 184 funds tracked by Wall St. Rank held Repligen as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.